Showing 1401-1410 of 1692 results for "".
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0708Epilepsy-pdf/31003/Complementary and Alternative Medical Therapies (CAMs) are increasingly utilized by patients with epilepsy, highlighting the necessity for healthcare professionals to be vigilant about their potential impacts. CAMs encompass a variety of treatments, including herbal medicines, dietary supplements, a
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31020/Recent advancements in stroke prevention highlight the critical role of rapid intervention following transient ischemic attacks (TIAs). Two pivotal studies, EXPRESS and SOS-TIA, provide robust evidence supporting immediate evaluation and treatment to significantly reduce the risk of subsequent strok
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31047/Recent advancements in Transient Ischemic Attack (TIA) management have been the focus of numerous publications, highlighting the critical need for updated approaches in clinical practice. A comprehensive meta-analysis encompassing 11 natural history studies with 7,238 patients underscores the elevat
- Mild Cognitive Impairment: Where Does it Fit In?https://practicalneurology.com/columns/practice-management/mild-cognitive-impairment-where-does-it-fit-in/31043/Summary:Mild Cognitive Impairment (MCI) has gained prominence in the neurological landscape, particularly in the digital age where awareness spreads rapidly. MCI represents a crucial intermediary stage between normal age-related cognitive decline and more severe dementias, such as Alzheimer’s diseas
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31077/In the December 2007 issue of Practical Neurology, Editor-in-Chief Jack Persico draws a poignant parallel between the classic film "It's a Wonderful Life" and the current state of neurology practice. Highlighting an article by Dr. Ronald DeVere, the discussion focuses on the pervasive issue of physi
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31118/Recent advancements in neurology highlight significant progress and emerging insights into Alzheimer’s disease (AD) and related neurological conditions. A pivotal study published in the FASEB Journal reveals that amyloid β-derived diffusible ligand (ADDL) in AD patients disrupts insulin signaling by
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31137/Clinical Insights: Recent Advances in NeurologyRecent genetic studies continue to illuminate the complex interplay between genetics and multiple sclerosis (MS). A genome-wide association study published in the *New England Journal of Medicine* identified heritable risk factors for MS, specifically a
- The Night Shift: Putting Sleep Studies to Work for Youhttps://practicalneurology.com/diseases-diagnoses/sleep/pn0707-sleep-studies-pdf/31153/Enhancing Neurological Diagnoses with Sleep StudiesSleep studies, particularly polysomnography (PSG), are becoming increasingly vital in neurology for accurately diagnosing sleep-related disorders. Despite patients’ reluctance to undergo overnight testing, the objective data obtained from PSGs provi
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0407-painmngmt-pdf/31193/Chronic Pain Management: Addressing Potential Bias in Clinical AssessmentsChronic pain remains a significant challenge in neurology, often complicated by the subjective nature of pain assessment. In the article "Are You Guilty of Bias When Encountering Unexplained Pain?" by Charles Argoff, MD, publi
- Levodopa: Life Begins at 40?https://practicalneurology.com/columns/practice-management/levodopa-life-begins-at-40/31189/Levodopa Remains Cornerstone in Parkinson’s Disease Therapy After 40 YearsForty years after the seminal 1967 Cotzias study, levodopa continues to be the primary treatment for Parkinson’s disease (PD), underscoring its enduring efficacy in managing motor symptoms. Levodopa’s journey from a laboratory